Design, synthesis and biological evaluation of a macrocyclic discodermolide/dictyostatin hybrid.
A 22-membered macrocyclic discodermolide/dictyostatin hybrid has been designed and synthesised; biological evaluation against a range of human cancer cell lines revealed significant levels of growth inhibition.